Weidong Han

Diagnosis and Treatment Guidelines for Mesenchymal Stem Cell Therapy for Coronavirus Disease 2019 (Beijing, 2021)

Zhongmin Liu, R. Xu, Jun‐liang Fu, 2021, Infectious Diseases & Immunity.

Efficacy Analysis of Nivolumab in Combination with Gemcitabine and Cisplatin in Patients with Unresectable or Metastatic Biliary Tract Cancers

Q. Mei, Yang Liu, Liang Dong, 2019, SSRN Electronic Journal.

Efficacy and safety of umbilical cord-derived mesenchymal stem cells in Chinese adults with type 2 diabetes: a single-center, double-blinded, randomized, placebo-controlled phase II trial

Y. Mu, Yu Cheng, Yaqi Yin, 2022, Stem Cell Research & Therapy.

Biomarkers of cytokine release syndrome and neurotoxicity related to CAR-T cell therapy

W. Han, Weidong Han, Zhenguang Wang, 2018, Biomarker Research.

Mesenchymal stem cells promote type 2 macrophage polarization to ameliorate the myocardial injury caused by diabetic cardiomyopathy

Zi-hui Deng, W. Han, P. Ye, 2019, Journal of Translational Medicine.

Decitabine assists umbilical cord-derived mesenchymal stem cells in improving glucose homeostasis by modulating macrophage polarization in type 2 diabetic mice

Y. Cheng, Lin Li, Y. Mu, 2019, Stem Cell Research & Therapy.

Expert consensus on microtransplant for acute myeloid leukemia in elderly patients -report from the international microtransplant interest group.

Ming-Yu Liu, Fei Li, D. Blaise, 2023, Heliyon.